
Research peptides
Selank
Selank is a seven-amino-acid peptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) created by Russian researchers. It takes tuftsin, a short piece of immunoglobulin G, and adds Pro-Gly-Pro on the end to make the molecule more stable.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 10 mg, lot SEL10-0803: 99.83% purity (RP-HPLC), 10.93 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7627
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Rodent behavior tests related to anxiety
- One small Russian study in generalized anxiety disorder
- Genes tied to GABA signaling
- Enzymes that break down enkephalins
How it is thought to work
There is no settled account of how Selank acts. Ideas put forward include slowing the enzymes that degrade enkephalins, nudging how GABA receptors bind their ligand in radioligand experiments, and altering which GABA-linked genes are active. The teams that created the peptide in Russia produced most of this evidence.
Where the research stands
Said to be approved in Russia; no FDA approval. Sources describe it as approved in Russia for anxiety. The human studies are small and written in Russian, one being a comparison against medazepam in 62 patients, and we found no sign of FDA approval.
Sources
- Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.. Front Pharmacol.
- Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, et al. (2008). [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].. Zh Nevrol Psikhiatr Im S S Korsakova.
- Zozulya AA, Kost NV, Yu Sokolov O, Gabaeva MV, et al. (2001). The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity.. Bull Exp Biol Med.
- Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N (2018). Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.. Protein Pept Lett.
- Rahman OF, Lee SJ, Seeds WA (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.. J Am Acad Orthop Surg Glob Res Rev.
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
